Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Scleroderma, Localized"
Show Display Options
Rank Status Study
1 Recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
2 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
3 Recruiting The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Condition: Scleroderma
Intervention:
4 Recruiting Duke Scleroderma Clinic Patient Registry
Conditions: Scleroderma;   Systemic Sclerosis
Intervention: Other: Registry
5 Recruiting Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Conditions: Scleroderma;   Ssc
Intervention: Other: Occupational therapy treatment
6 Recruiting Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: atorvastatin;   Drug: Placebo
7 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
8 Recruiting Scleroderma Registry & Repository at the Hospital for Special Surgery
Condition: Scleroderma
Intervention:
9 Recruiting Scleroderma Registry
Conditions: Systemic Sclerosis;   Scleroderma
Intervention:
10 Recruiting Calcinosis in a Single-Center Scleroderma Population
Conditions: Scleroderma;   Calcinosis
Intervention:
11 Recruiting IL1-TRAP, Rilonacept, in Systemic Sclerosis
Conditions: Scleroderma;   Systemic Sclerosis;   Diffuse Scleroderma;   Diffuse Systemic Sclerosis
Interventions: Drug: Rilonacept;   Drug: Placebo
12 Recruiting Riociguat in Scleroderma Associated Digital Ulcers
Conditions: Scleroderma,;   Digital Ulcers
Interventions: Drug: Riociguat;   Drug: Placebo
13 Recruiting Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers
Condition: Digital Ulcer of Scleroderma
Interventions: Drug: Diltiazem Gel 2%;   Drug: Nitroglycerin Ointment 0.2%;   Drug: Vaseline with Vit E
14 Recruiting Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Conditions: Scleroderma;   Interstitial Lung Disease
Intervention: Drug: dabigatran etexilate
15 Recruiting Zibotentan Better Renal Scleroderma Outcome Study
Conditions: Scleroderma;   Scleroderma Renal Crisis;   Chronic Kidney Disease
Intervention: Drug: Zibotentan
16 Recruiting Gastroesophageal Reflux Treatment in Scleroderma
Conditions: Gastroesophageal Reflux Disease;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Alginic acid;   Drug: placebo (for domperidone);   Drug: Domperidone;   Drug: placebo (of alginic acid)
17 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
18 Recruiting Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
Conditions: Scleroderma, Systemic;   Sleep Apnea, Obstructive;   Pulmonary Disease
Intervention: Other: No intervention
19 Recruiting Microvascular and Fibrosis Imaging Study
Conditions: Autoimmune Diseases;   Sickle Cell Disease;   Chronic Graft Versus Host Disease
Interventions: Other: Acoustic Radiation Force Impulse (ARFI);   Other: Laser Doppler Flowmetry (LDF);   Other: Laser Doppler Perfusion Imaging (LDI);   Other: Optical Coherence Tomography (OCT);   Other: Orthogonal Polarization Spectral Imaging (OPSI);   Other: Nail fold video capillaroscopy (NVC)

Study has passed its completion date and status has not been verified in more than two years.